title: Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers.
abstract: The Affordable Care Act (ACA) has been heralded as a major policy change that is expected to transform the delivery of substance use disorder (SUD) treatment. Few studies have reported on the perceived impacts of ACA from the perspectives of SUD treatment providers, such as physicians who prescribe buprenorphine to patients with opioid use disorder. The present study describes buprenorphine prescribers' perceptions regarding impacts of the ACA on the delivery of buprenorphine and examines whether state-level approaches to implementing ACA are associated with its perceived impacts. Data are drawn from a national sample of current buprenorphine prescribers (n = 1,174) who were surveyed by mail. On average, buprenorphine prescribers reported ambivalence regarding the impacts of the ACA, as indicated by a mean of 2.75 (SD = 0.69) on a scale that ranged from 1 ("strongly disagree") to 5 ("strongly agree"). A multi-level mixed-effects regression model indicated that physicians practicing in states that were supportive of ACA, as indicated by adopting both the Medicaid expansion and implementing a state-based health insurance exchange, had more positive perceptions of the ACA than physicians in states that had declined both of these policies. This study suggests that state approaches to ACA may be associated with varied impacts.
authors.affiliation: a Associate Professor, Center on Drug and Alcohol Research , University of Kentucky , Lexington , KY , USA.|b Associate Professor, Department of Behavioral Science , University of Kentucky , Lexington , KY , USA.
authors.forename: Hannah K
authors.initials: HK
authors.lastname: Knudsen
authors.affiliation: b Associate Professor, Department of Behavioral Science , University of Kentucky , Lexington , KY , USA.
authors.forename: Jamie L
authors.initials: JL
authors.lastname: Studts
mesh_terms: D000328:Adult; D000368:Aged; D001291:Attitude of Health Personnel; D002047:Buprenorphine / Q000008:administration & dosage*; D005260:Female; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D008484:Medicaid; D008875:Middle Aged; D058850:Opiate Substitution Treatment / Q000379:methods; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D058991:Patient Protection and Affordable Care Act; D010465:Perception; D010820:Physicians / Q000706:statistics & numerical data*; D014481:United States
chemical_list: D002047:Buprenorphine
keywords: Affordable Care Act; buprenorphine; health reform; physician survey; substance use disorder treatment delivery